文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

阿根廷首季孕产妇RSVpreF免疫后婴儿严重RSV疾病残余负担研究

Residual burden of severe RSV disease in infants during the first season of maternal RSVpreF immunization in Argentina: A hospital-based, multicentre, retrospective cohort study.
PubMed 文献 · Vaccine · 2026-05-29

该多中心回顾性队列研究利用RIMA网络覆盖布宜诺斯艾利斯大都会区五家三级医院,分析2024年首个免疫后季节与2018-2023年历史数据中<12月龄婴儿RSV相关住院情况。结果显示首季RSV住院婴儿中91.73%的母亲未接种疫苗,主要保护缺口为时间性,43.18%的<6月龄住院婴儿在接种活动开始前出生,88.52%需PICU入住。

要点

  • 首季RSV住院婴儿中91.73%的母亲未接种RSVpreF疫苗。
  • 43.18%的<6月龄住院婴儿在接种活动启动前出生,构成主要保护缺口。
  • 88.52%的RSV住院婴儿需PICU入住,严重疾病负担持续存在。

核心结论

  • 孕产妇RSVpreF免疫实施后首季,阿根廷婴儿仍存在大量严重RSV住院残余负担。
  • 残余负担主要由接种窗口外出生的婴儿和高危早产儿队列驱动。

研究设计与样本

  • 多中心回顾性队列研究,利用RIMA网络覆盖布宜诺斯艾利斯大都会区五家三级医院。
  • 分析2024年首个免疫后季节<12月龄婴儿RSV相关住院,并与2018-2023年历史数据比较。

主要发现

  • 研究期间共10,860例<12月龄婴儿因ALRTI住院,其中3,967例(36.29%)RSV阳性。
  • 首季RSV住院婴儿中91.73%(477/520)的母亲未接种疫苗。
  • 2024年<6月龄住院婴儿中43.18%(133/308)在接种活动开始前出生。
  • 131/148例(88.52%)RSV住院婴儿需PICU入住。

关键数值与推荐

  • 首季RSV住院婴儿母亲未接种比例为91.73%(477/520)。
  • 2024年<6月龄住院婴儿中接种前出生比例为43.18%(133/308)。
  • RSV住院婴儿需PICU入住比例为88.52%(131/148)。

临床怎么用

  • 需关注接种窗口外出生的婴儿和高危早产儿队列的RSV防护缺口。
  • 建议协调策略,将长效单克隆抗体与孕产妇疫苗整合以弥合保护缺口。

局限性

  • 本研究为回顾性设计,且仅覆盖布宜诺斯艾利斯大都会区五家三级医院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Argentina pioneered the implementation of maternal immunization (MI) with RSVpreF to prevent RSV hospitalizations in infants. This study aims to assess the residual burden of RSV-related hospitalizations in infants under 12 months during Argentina's first season of MI. METHODS: This multicentre, retrospective cohort study utilized the RIMA network across five tertiary hospitals in the Metropolitan Area of Buenos Aires. We analysed RSV-related hospitalizations in infants <12 months old during the first post-MI season (2024) and compared them with historical data (2018-2023). The primary objective was to characterize the "protection gap" among hospitalized infants. FINDINGS: Overall, 10,860 infants aged <12 months were hospitalized with ALRTI during the study; 3967 (36.29%) were RSV-positive. During the first vaccination season, 91.73% (477/520) of RSV-hospitalized infants were born to unvaccinated mothers. The primary protection gap was temporal: 43.18% (133/308) of infants under 6 months hospitalized during 2024 were born before the vaccination campaign started. Severe RSV disease remained prevalent, with 131/148 infants (88.52%) requiring PICU admission. INTERPRETATIONS: While maternal immunization is a landmark intervention, a substantial residual burden of severe RSV remains in Argentina. This burden is driven by infants born outside the vaccination window and high-risk preterm cohorts. To achieve comprehensive protection, coordinated strategies, including the integration of long-acting monoclonal antibodies alongside maternal vaccines, are necessary to close existing equity and protection gaps. FUNDING: This work was supported by SANOFI and AstraZeneca (RSV00105).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dvorkin J, Pico M, Guiñazú G, et al. Residual burden of severe RSV disease in infants during the first season of maternal RSVpreF immunization in Argentina: A hospital-based, multicentre, retrospective cohort study. Vaccine. 2026. PMID: 42214177. doi:10.1016/j.vaccine.2026.128773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。